We are live on ! Find out more

Small Cap Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
XNCR icon
1
Xencor
XNCR
$1.98B
$1.98B $26.61 0.04%
AGIO icon
2
Agios Pharmaceuticals
AGIO
$1.98B
$1.98B $33.10 0.09%
NBTX
3
Nanobiotix
NBTX
$1.97B
$1.97B $38.80 3%
KARD
4
Kardigan Inc
KARD
$1.95B
$1.95B $20.85 0.53%
RXRX icon
5
Recursion Pharmaceuticals
RXRX
$1.95B
$1.95B $3.63 5.52%
GHRS icon
6
GH Research
GHRS
$1.94B
$1.94B $28.23 1.11%
VIR icon
7
Vir Biotechnology
VIR
$1.93B
$1.93B $11.38 0.61%
STOK icon
8
Stoke Therapeutics
STOK
$1.92B
$1.92B $29.81 0.6%
LKFT
9
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.87B
$1.87B $28.49 1.83%
IMCR icon
10
Immunocore
IMCR
$1.86B
$1.86B $36.13 3.83%
DMRA
11
Damora Therapeutics
DMRA
$1.86B
$1.86B $30.06 7.36%
SNDX icon
12
Syndax Pharmaceuticals
SNDX
$1.84B
$1.84B $20.56 0.58%
TSHA icon
13
Taysha Gene Therapies
TSHA
$1.82B
$1.82B $5.60 0.54%
NTLA icon
14
Intellia Therapeutics
NTLA
$1.79B
$1.79B $12.74 0.47%
INBX icon
15
Inhibrx
INBX
$1.78B
$1.78B $121.17 0.89%
SEPN
16
Septerna Inc
SEPN
$1.72B
$1.72B $36.75 0.14%
TYRA icon
17
Tyra Biosciences
TYRA
$1.71B
$1.71B $28.65 15.2%
NVAX icon
18
Novavax
NVAX
$1.69B
$1.69B $10.22 1.16%
FTRE icon
19
Fortrea Holdings
FTRE
$1.68B
$1.68B $17.70 4.94%
ANAB icon
20
AnaptysBio
ANAB
$1.68B
$1.68B $56.80 1.15%
AVLN
21
Avalyn Pharma
AVLN
$1.66B
$1.66B $37.39 5.5%
AAPG
22
Ascentage Pharma
AAPG
$1.64B
$1.64B $17.61 1.44%
SLBT
23
SL Science Holding Ltd
SLBT
$1.61B
$1.61B $2.88 8.57%
LBRX
24
LB Pharmaceuticals
LBRX
$1.59B
$1.59B $49.34 3.83%
INVA icon
25
Innoviva
INVA
$1.54B
$1.54B $21.33 0.09%
1
2 3 4 5

Small Cap Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 191 small cap Biotechnology stocks — companies in the Biotechnology industry with a market cap between $250M and $2B — worth a combined $165B.

The largest by market cap are Xencor (XNCR) at $1.98B, Agios Pharmaceuticals (AGIO) at $1.98B and Nanobiotix (NBTX) at $1.97B.

Among institutional investors, First Tracks Biotherapeutics (TRAX) drew the most net new fund positions in Q2 2026: 150 funds opened new positions.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.